More than 600 people will take part in study to test a promising treatment for Huntington's disease, a fatal inherited condition. The experimental drug interferes with defective genetic machinery.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,